Smithfield Trust’s Chemours CC Stock Holding History

Smithfield Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22K	Hold	1,005	–	–	﹤0.01%	744
2025 Q4	$12K	Hold	1,005	–	–	﹤0.01%	855
2025 Q3	$16K	Hold	1,005	–	–	﹤0.01%	787
2025 Q2	$12K	Sell	1,005 -40	-4%	-$451	﹤0.01%	828
2025 Q1	$14K	Sell	1,045 -170	-14%	-$2.82K	﹤0.01%	799
2024 Q4	$21K	Hold	1,215	–	–	﹤0.01%	733
2024 Q3	$24K	Hold	1,215	–	–	﹤0.01%	676
2024 Q2	$28K	Hold	1,215	–	–	﹤0.01%	624
2024 Q1	$31K	Hold	1,215	–	–	﹤0.01%	639
2023 Q4	$38K	Hold	1,215	–	–	﹤0.01%	588
2023 Q3	$34K	Hold	1,215	–	–	﹤0.01%	586
2023 Q2	$44K	Hold	1,215	–	–	﹤0.01%	570
2023 Q1	$35K	Hold	1,215	–	–	﹤0.01%	580
2022 Q4	$38K	Hold	1,215	–	–	﹤0.01%	559
2022 Q3	$30K	Hold	1,215	–	–	﹤0.01%	579
2022 Q2	$38K	Hold	1,215	–	–	﹤0.01%	575
2022 Q1	$38K	Hold	1,215	–	–	﹤0.01%	597
2021 Q4	$40K	Hold	1,215	–	–	﹤0.01%	593
2021 Q3	$35K	Hold	1,215	–	–	﹤0.01%	614
2021 Q2	$43K	Hold	1,215	–	–	﹤0.01%	575
2021 Q1	$34K	Hold	1,215	–	–	﹤0.01%	611
2020 Q4	$30K	Sell	1,215 -100	-8%	-$2.38K	﹤0.01%	599
2020 Q3	$28K	Buy	1,315 +150	+13%	+$2.9K	﹤0.01%	586
2020 Q2	$18K	Buy	1,165 +247	+27%	+$3.12K	﹤0.01%	634
2020 Q1	$8K	Buy	918 +40	+5%	+$577	﹤0.01%	710
2019 Q4	$16K	Hold	878	–	–	﹤0.01%	644
2019 Q3	$13K	Sell	878 -284	-24%	-$4.62K	﹤0.01%	703
2019 Q2	$28K	Hold	1,162	–	–	﹤0.01%	599
2019 Q1	$44K	Hold	1,162	–	–	﹤0.01%	506
2018 Q4	$33K	Hold	1,162	–	–	﹤0.01%	526
2018 Q3	$46K	Buy	1,162 +284	+32%	+$12.4K	0.01%	545
2018 Q2	$39K	Sell	878 -3,710	-81%	-$185K	﹤0.01%	562
2018 Q1	$223K	Sell	4,588 -163	-3%	-$8.15K	0.03%	250
2017 Q4	$238K	Buy	4,751 +170	+4%	+$8.9K	0.03%	242
2017 Q3	$232K	Sell	4,581 -210	-4%	-$9.91K	0.03%	243
2017 Q2	$182K	Buy	4,791 +4,020	+521%	+$159K	0.03%	297
2017 Q1	$30K	Sell	771 -24	-3%	-$722	﹤0.01%	596
2016 Q4	$17K	Hold	795	–	–	﹤0.01%	652
2016 Q3	$13K	Sell	795 -161	-17%	-$1.84K	﹤0.01%	677
2016 Q2	$8K	Sell	956 -149	-13%	-$1.33K	﹤0.01%	705
2016 Q1	$8K	Sell	1,105 -76	-6%	-$382	﹤0.01%	710
2015 Q4	$7K	Sell	1,181 -100	-8%	-$639	﹤0.01%	730
2015 Q3	$8K	Buy	+1,281	New	+$13.4K	﹤0.01%	694

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Smithfield Trust's CC Position: Q1 2026 in Review

Smithfield Trust held its Chemours (CC) position steady in Q1 2026 at 1,005 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Smithfield Trust first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $238K in Q4 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Smithfield Trust held 1,005 shares of Chemours worth $22K as of Q1 2026.
Smithfield Trust left its Chemours share count unchanged in Q1 2026.
Chemours made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #744 holding.
Smithfield Trust first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
Smithfield Trust's Chemours position peaked at $238K in Q4 2017.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.